BioCentury
ARTICLE | Company News

Enzon Inc. enabling technology news

March 15, 1999 8:00 AM UTC

ENZN formed SCA Ventures as a wholly-owned subsidiary to commercialize its Single-Chain Antigen-Binding (SCA) protein technology. ENZN, which has several licensees for the technology, said SCA protein...